Agnes Pasquet
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Agnes Pasquet has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- David Vancraeynest
Division of Cardiology, Department of Cardiovascular Diseases, Cliniques Universitaires St. Luc UCL, Av Hippocrate 10/2806, B-1200, Woluwé St. Lambert, Belgium
11 shared publications - Jean-Louis Vanoverschelde
Pôle de Recherche Cardiovasculaire, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium; Division of Cardiology, Cliniques Universitaires Saint-Luc, Brussels, Belgium
11 shared publications - Anne-Catherine Pouleur
Cardiovascular Department, Cliniques universitaires Saint-Luc, Brussels, Belgium
9 shared publications - Christophe de Meester
Division of Cardiology, Department of Cardiovascular Diseases, Cliniques Universitaires St. Luc UCL, Av Hippocrate 10/2806, B-1200, Woluwé St. Lambert, Belgium
8 shared publications Bernhard Gerber
Cliniques Universitaires St Luc
6 shared publications- Bernhard L. Gerber
Division of Cardiology, Cardiovascular Department, Cliniques Universitaires Saint-Luc and Institut de Recherche Experimentale et Clinique (IRECT), UCLouvain, Brussels, Belgium
6 shared publications
Latest Publications
- 27 November 2018
- Published by Springer Nature
- p. 521-540
Assessing Myocardial Viability: Principles and the Role of Echocardiography
- 27 November 2018
- Published by Springer Nature
- p. 521-540
Assessing Myocardial Viability: Principles and the Role of Echocardiography
- Open Access
- 1 February 2018
- Published by Elsevier in Journal of Cardiovascular Magnetic Resonance
- Vol. 20 (1) , 55-12
Associations and prognostic significance of diffuse myocardial fibrosis by cardiovascular magnetic resonance in heart failure with preserved ejection fraction
- 1 February 2018
- Published by Elsevier in Journal of Cardiovascular Magnetic Resonance
- Vol. 20 (1) , 55-12
Open AccessAssociations and prognostic significance of diffuse myocardial fibrosis by cardiovascular magnetic resonance in heart failure with preserved ejection fraction
- Open Access
- 1 December 2016
- Published by Elsevier in Journal of Cardiovascular Magnetic Resonance
- Vol. 19 (1) , 72-12
Age and sex corrected normal reference values of T1, T2 T2* and ECV in healthy subjects at 3T CMR
- 1 December 2016
- Published by Elsevier in Journal of Cardiovascular Magnetic Resonance
- Vol. 19 (1) , 72-12
Open AccessAge and sex corrected normal reference values of T1, T2 T2* and ECV in healthy subjects at 3T CMR
- Open Access
- 1 December 2016
- Published by Elsevier in Journal of Cardiovascular Magnetic Resonance
- Vol. 19 (1) , 37-10
Impact of left ventricular outflow tract ellipticity on the grading of aortic stenosis in patients with normal ejection fraction
- 1 December 2016
- Published by Elsevier in Journal of Cardiovascular Magnetic Resonance
- Vol. 19 (1) , 37-10
Open AccessImpact of left ventricular outflow tract ellipticity on the grading of aortic stenosis in patients with normal ejection fraction
- Open Access
- 12 January 2016
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 16 (1) , 7
The clinical impact of valvular heart disease in a population-based cohort of subjects aged 80 and older
In our ageing society, valvular heart diseases (VHD) have become an increasing public health problem. However, the lack of studies describing the impact of these diseases on the outcome of very old subjects makes it difficult to appreciate their real clinical burden. Prospective, observational, population-based cohort study in Belgium. Five hundred fifty six subjects aged 80 years and older were followed up for 5.1 ± 0.25 years for mortality and 3.0 ± 0.25 years for hospitalization. Echocardiograms were performed at baseline. The Cumulative Illness Rating Scale (CIRS) was calculated for each subject. The prevalence of moderate-to-severe VHD was 17 % (n = 97). Mitral stenosis was more prevalent in women and an age-dependent increase of the prevalence of severe aortic stenosis was seen. The overall disease burden was higher in participants with VHD (median CIRS 3 [IQR 3–5] vs 4 [IQR 3–6] (P = 0.008)). Moderate-to-severe VHD, and more specifically mitral stenosis and aortic stenosis, was found to be an independent predictor of both all-cause (HR 1.42 (95 % CI 1.04–1.95)) and cardiovascular mortality (HR 2.13 (95 % CI 1.38–3.29)). Moderate-to-severe VHD was also found to be an independent predictor of the need for a first unplanned hospitalization (HR 1.43 (95 % CI 1.06–1.94)). A high prevalence of moderate-to-severe VHD was found in the very old. Moderate-to-severe VHD was identified as an independent risk factor for all-cause and cardiovascular mortality and as well for unplanned hospitalizations, independent of other structural cardiac abnormalities, ventricular function and major co-morbidities.
- 12 January 2016
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 16 (1) , 7
Open AccessThe clinical impact of valvular heart disease in a population-based cohort of subjects aged 80 and older
In our ageing society, valvular heart diseases (VHD) have become an increasing public health problem. However, the lack of studies describing the impact of these diseases on the outcome of very old subjects makes it difficult to appreciate their real clinical burden. Prospective, observational, population-based cohort study in Belgium. Five hundred fifty six subjects aged 80 years and older were followed up for 5.1 ± 0.25 years for mortality and 3.0 ± 0.25 years for hospitalization. Echocardiograms were performed at baseline. The Cumulative Illness Rating Scale (CIRS) was calculated for each subject. The prevalence of moderate-to-severe VHD was 17 % (n = 97). Mitral stenosis was more prevalent in women and an age-dependent increase of the prevalence of severe aortic stenosis was seen. The overall disease burden was higher in participants with VHD (median CIRS 3 [IQR 3–5] vs 4 [IQR 3–6] (P = 0.008)). Moderate-to-severe VHD, and more specifically mitral stenosis and aortic stenosis, was found to be an independent predictor of both all-cause (HR 1.42 (95 % CI 1.04–1.95)) and cardiovascular mortality (HR 2.13 (95 % CI 1.38–3.29)). Moderate-to-severe VHD was also found to be an independent predictor of the need for a first unplanned hospitalization (HR 1.43 (95 % CI 1.06–1.94)). A high prevalence of moderate-to-severe VHD was found in the very old. Moderate-to-severe VHD was identified as an independent risk factor for all-cause and cardiovascular mortality and as well for unplanned hospitalizations, independent of other structural cardiac abnormalities, ventricular function and major co-morbidities.
- Open Access
- 1 January 2015
- Published by Elsevier in Journal of Cardiovascular Magnetic Resonance
- Vol. 17 (1) , 48-11
Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T
- 1 January 2015
- Published by Elsevier in Journal of Cardiovascular Magnetic Resonance
- Vol. 17 (1) , 48-11
Open AccessHistological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T